Skip to main content
SpringerLink
Log in

Osteogenic Sarcoma and Dedifferentiated Chondrosarcoma Surveillance Counterpoint: Japan

  • Chapter
  • First Online:
Patient Surveillance After Cancer Treatment

Part of the book series: Current Clinical Oncology ((CCO))

  • 131 Accesses

Abstract

Osteosarcoma is a primary malignant tumor of the skeleton characterized by its production of osteoid matrix. The classic osteosarcoma is rare, with an estimated incidence of two cases/million population/year in Japan. It is most common in males and occurs primarily in the second decade of life. Years ago patients with osteosarcoma were treated with surgical resection only, with more than 80 % of the patients ultimately dying of this disease. Today osteosarcoma is treated with pre- and postoperative chemotherapy plus surgery, and the percentage of patients cured varies between 60 and 70 % [1, 2].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 249.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Picci P. Osteosarcoma (osteogenic sarcoma). Orphanet J Rare Dis. 2007;2:6.

    Article  PubMed  Google Scholar 

  2. Gebhardt MC, Hornicek FJ. Osteosarcoma. In: Menedenz LR, ­editor. Orthopaedic knowledge update: musculoskeletal tumors. Rosemont, IL: American Academy of Orthopaedic Surgeons; 2002. p. 175–86.

    Google Scholar 

  3. Dickey ID, Rose PS, Fuchs B, et al. Dedifferentiated chondrosarcoma: the role of chemotherapy with updated outcomes. J Bone Joint Surg Am. 2004;86:2412–8.

    PubMed  Google Scholar 

  4. Mitchell AD, Ayoub K, Mangham DC, Grimer RJ, Carter SR, Tillman RM. Experience in the treatment of dedifferentiated chondrosarcoma. J Bone Joint Surg Br. 2000;82:55–61.

    Article  PubMed  CAS  Google Scholar 

  5. Sakamoto A, Iwamoto Y. Current status and perspectives regarding the treatment of osteosarcoma: chemotherapy. Rev Recent Clin Trials. 2008;3:228–31.

    Article  PubMed  CAS  Google Scholar 

  6. Bielack SS, Carrle D. State-of-the-art approach in selective curable tumors: bone sarcoma. Ann Oncol. 2008;19 Suppl 7:vii155–60.

    Article  PubMed  Google Scholar 

  7. Gelderblom H, Hogendoorn PC, Dijkstra SD, et al. The clinical approach towards chondrosarcoma. Oncologist. 2008;13:320–9.

    Article  PubMed  Google Scholar 

  8. Brenner W, Bohuslavizki KH, Eary JF. PET imaging of osteosarcoma. J Nucl Med. 2003;44:930–42.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Orthopaedic Surgery, Kyushu University, 3-1-1 Maidashi, Higashiku, Fukuoka city, 812-8582, Japan

    Shuichi Matsuda M.D., Ph.D. & Yukihide Iwamoto M.D., Ph.D.

Authors
  1. Shuichi Matsuda M.D., Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yukihide Iwamoto M.D., Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Shuichi Matsuda M.D., Ph.D. .

Editor information

Editors and Affiliations

  1. Department of Surgery, Saint Louis University, Vista Avenue 3635, St. Louis, 63110-0050, Missouri, USA

    Frank E. Johnson

  2. Fac. Medicine, Dept. Surgery II, Kyushu University, Fukuoka, 812-8582, Japan

    Yoshihiko Maehara

  3. BC Cancer Agency, West 10th Avenue 600, Vancouver, V5Z 4E6, British Columbia, Canada

    George P. Browman

  4. School of Medicine, Washington University, S. Euclid Ave. 660, St. Louis, 63110, Missouri, USA

    Julie A. Margenthaler

  5. St Helens Teaching Hospital, University of Liverpool, Marshalls Cross Road, St Helens, WA9 3DA, United Kingdom

    Riccardo A. Audisio

  6. Sydney Cancer Centre, Sydney Melanoma Unit, Royal Prince Alfred Hospital, Missenden Road, Camperdown, 2050, New South Wales, Australia

    John F. Thompson

  7. Saint Louis University Medical Center, Saint Louis, 63103, Missouri, USA

    David Y. Johnson

  8. Dana-Farber Cancer Institute, Harvard Medical School, Binney St. 44, Boston, 02115, Massachusetts, USA

    Craig C. Earle

  9. International Atlantic Economic Society, Peachtree Center 299, NEInternatio, Atlanta, 30303, Georgia, USA

    Katherine S. Virgo

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Humana Press

About this chapter

Cite this chapter

Matsuda, S., Iwamoto, Y. (2013). Osteogenic Sarcoma and Dedifferentiated Chondrosarcoma Surveillance Counterpoint: Japan. In: Johnson, F., et al. Patient Surveillance After Cancer Treatment. Current Clinical Oncology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-60327-969-7_47

Download citation

  • DOI: https://doi.org/10.1007/978-1-60327-969-7_47

  • Published:

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-60327-968-0

  • Online ISBN: 978-1-60327-969-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation